for the Period Ended 31 January 2025
Balance sheet | |
Notes |
As at
Notes |
1 month to 31 January 2025 |
18 months to 31 December 2024 |
|
---|---|---|---|
|
£ |
£ |
|
Fixed assets | |||
Investments: | 3 |
|
|
Total fixed assets: |
|
|
|
Current assets | |||
Debtors: |
|
||
Cash at bank and in hand: |
|
|
|
Total current assets: |
|
|
|
Creditors: amounts falling due within one year: | 4 |
( |
( |
Net current assets (liabilities): |
( |
( |
|
Total assets less current liabilities: |
|
|
|
Creditors: amounts falling due after more than one year: | 5 |
( |
( |
Total net assets (liabilities): |
|
|
|
Capital and reserves | |||
Called up share capital: |
|
|
|
Profit and loss account: |
|
|
|
Shareholders funds: |
|
|
The notes form part of these financial statements
The directors have chosen to not file a copy of the company’s profit & loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 January 2025
for the Period Ended 31 January 2025
1 month to 31 January 2025 | 18 months to 31 December 2024 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 31 January 2025
The company owns 100% of the issued share capital of Wickham Market Medical Centre Ltd, a company incorporated in England and Wales. The subsidiary’s principal activity is the operation of a pharmacy. The investment in its subsidiary is stated at cost less any provision for impairment in value. Management have reviewed the carrying value of the investment and concluded that no impairment is required as the subsidiary continues to generate positive cash flows and profits.
for the Period Ended 31 January 2025
for the Period Ended 31 January 2025
for the Period Ended 31 January 2025
Name of the related party: |
|
|
Relationship: |
Wholly owned subsidiary
|
|
Description of the Transaction: |
|
|
£ | ||
Balance at 01 January 2025 |
|
|
Balance at 31 January 2025 |
|
Name of the related party: |
|
|
Relationship: |
Director
|
|
Description of the Transaction: |
|
|
£ | ||
Balance at 01 January 2025 |
|
|
Balance at 31 January 2025 |
|